MCMedicalCodingSoftware
Free trial
XW0V3WA

XW0V3WA — Introduction of AGN1 Bone Void Filler into Bones, Percutaneous Approach, New Technology Group 10

Billable / specific codeICD-10-PCS

CMS abbreviated title: Introduce AGN1 Bone Void Filler in Bones, Perc, New Tech 10

How XW0V3WA is built

Every ICD-10-PCS code is seven independent character positions. Each one is a separate decision, and the meaning of a character depends on the positions before it.

  1. XSectionNew Technology — What family of procedure this is
  2. WBody systemWhich system it acts on
  3. 0Root operationThe objective — the verb of the procedure
  4. VBody partThe specific site
  5. 3ApproachHow the site was reached
  6. WDeviceWhat was left in place, if anything
  7. AQualifierA further distinction where one applies

Codes near XW0V3WA

In CMS’s own ordering, which groups codes that differ by only the last character or two — usually the approach, device or qualifier.

  • XW0M3KAIntroduction of Paclitaxel-Coated Balloon Technology, Three Balloons into Coronary Artery, Four or More Arteries, Percutaneous Approach, New Technology Group 10
  • XW0M3LAIntroduction of Paclitaxel-Coated Balloon Technology, Four or More Balloons into Coronary Artery, Four or More Arteries, Percutaneous Approach, New Technology Group 10
  • XW0Q316Introduction of Eladocagene exuparvovec into Cranial Cavity and Brain, Percutaneous Approach, New Technology Group 6
  • XW0U0GAIntroduction of Vancomycin Hydrochloride and Tobramycin Sulfate Anti-Infective, Temporary Irrigation Spacer System into Joints, Open Approach, New Technology Group 10
  • XW0U0XBIntroduction of Peptide Enhanced Bone Void Filler into Joints, Open Approach, New Technology Group 11
  • XW0U3XBIntroduction of Peptide Enhanced Bone Void Filler into Joints, Percutaneous Approach, New Technology Group 11
  • XW0U4XBIntroduction of Peptide Enhanced Bone Void Filler into Joints, Percutaneous Endoscopic Approach, New Technology Group 11
  • XW0V0P7Introduction of Antibiotic-eluting Bone Void Filler into Bones, Open Approach, New Technology Group 7
  • XW0V3WAIntroduction of AGN1 Bone Void Filler into Bones, Percutaneous Approach, New Technology Group 10
  • XW13325Transfusion of Convalescent Plasma (Nonautologous) into Peripheral Vein, Percutaneous Approach, New Technology Group 5
  • XW1337ATransfusion of Marnetegragene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 10
  • XW133B8Transfusion of Betibeglogene Autotemcel into Peripheral Vein, Percutaneous Approach, New Technology Group 8
  • XW133C8Transfusion of Omidubicel into Peripheral Vein, Percutaneous Approach, New Technology Group 8
  • XW133D7Transfusion of High-Dose Intravenous Immune Globulin into Peripheral Vein, Percutaneous Approach, New Technology Group 7
  • XW133E7Transfusion of Hyperimmune Globulin into Peripheral Vein, Percutaneous Approach, New Technology Group 7
  • XW133F8Transfusion of OTL-103 into Peripheral Vein, Percutaneous Approach, New Technology Group 8
ICD-10-PCSFY2026